Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2017 | 06-2016 | 06-2015 | 06-2014 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 407 | -1,381 | -24,318 | -15,908 | -4,990 |
| Depreciation Amortization | 912 | 567 | 376 | 334 | 285 |
| Accounts payable and accrued liabilities | -333 | 140 | 228 | 156 | 674 |
| Other Working Capital | -38,375 | 65,714 | 1,479 | -524 | 688 |
| Other Operating Activity | 6,388 | 5,951 | 2,750 | 4,014 | 566 |
| Operating Cash Flow | $-31,001 | $70,991 | $-19,485 | $-11,928 | $-2,777 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 35,702 | -98,212 | 18,215 | -50,450 | -13,950 |
| PPE Investments | -891 | -2,592 | -323 | -376 | -531 |
| Other Investing Activity | -2,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $32,811 | $-100,804 | $17,892 | $-50,826 | $-14,481 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 507 |
| Debt Repayment | N/A | N/A | N/A | -1 | -857 |
| Common Stock Issued | 28 | 19,494 | 32,157 | 51,801 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 10,684 | 25,727 |
| Financing Cash Flow | $28 | $19,494 | $32,157 | $62,484 | $25,377 |
| Beginning Cash Position | 28,868 | 39,187 | 8,623 | 8,893 | 774 |
| End Cash Position | 30,706 | 28,868 | 39,187 | 8,623 | 8,893 |
| Net Cash Flow | $1,838 | $-10,319 | $30,564 | $-270 | $8,119 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,001 | 70,991 | -19,485 | -11,928 | -2,777 |
| Capital Expenditure | -891 | -2,592 | -323 | -376 | -531 |
| Free Cash Flow | -31,892 | 68,399 | -19,808 | -12,304 | -3,308 |